Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers


Ontology type: sgo:Patent     


Patent Info

DATE

1992-10-27T00:00

AUTHORS

Alexander R. Neurath , Stephen B. H. Kent

ABSTRACT

A hepatitis B vaccine containing a peptide with an amino acid chain of at least six consecutive amino acids within the pre-S gene coded region of the envelope of hepatitis B virus. The vaccine being free of an amino acid sequence corresponding to the naturally occurring envelope proteins of hepatitis B virus and a physiologically acceptable diluent. The peptide being free or linked to a carrier. The carrier being a conventional carrier or a novel carrier including a lipid vesicle stabilized by cross-linking and having covalently bonded active sites on the outer surface thereon. Such novel carrier being useful not only to link the novel peptide containing an amino acid chain with amino acids within the pre-S gene coded region of the surface antigen of hepatitis B virus, but can also be used to bind synthetic peptide analogues of other viral proteins, as well as bacterial, allergen and parasitic proteins of man and animals. The peptides of the invention can be utilized in diagnostics for the detection of antigens and antibodies. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3114", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Alexander R. Neurath", 
        "type": "Person"
      }, 
      {
        "name": "Stephen B. H. Kent", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf02327089", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023829055", 
          "https://doi.org/10.1007/bf02327089"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02327089", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023829055", 
          "https://doi.org/10.1007/bf02327089"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/289373a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032880486", 
          "https://doi.org/10.1038/289373a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm198502213120806", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034031480"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.79.24.7871", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034374371"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/08820138309066866", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035831916"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.80.16.4949", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039287430"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000149327", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040985468"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/295158a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042872425", 
          "https://doi.org/10.1038/295158a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.78.6.3824", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047301083"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/317145a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048446499", 
          "https://doi.org/10.1038/317145a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/318663a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052023912", 
          "https://doi.org/10.1038/318663a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.6200931", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062635706"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/j.1460-2075.1982.tb01262.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1081617042"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1992-10-27T00:00", 
    "description": "

A hepatitis B vaccine containing a peptide with an amino acid chain of at least six consecutive amino acids within the pre-S gene coded region of the envelope of hepatitis B virus. The vaccine being free of an amino acid sequence corresponding to the naturally occurring envelope proteins of hepatitis B virus and a physiologically acceptable diluent. The peptide being free or linked to a carrier. The carrier being a conventional carrier or a novel carrier including a lipid vesicle stabilized by cross-linking and having covalently bonded active sites on the outer surface thereon. Such novel carrier being useful not only to link the novel peptide containing an amino acid chain with amino acids within the pre-S gene coded region of the surface antigen of hepatitis B virus, but can also be used to bind synthetic peptide analogues of other viral proteins, as well as bacterial, allergen and parasitic proteins of man and animals. The peptides of the invention can be utilized in diagnostics for the detection of antigens and antibodies.

", "id": "sg:patent.US-5158769-A", "keywords": [ "immunogen", "vaccine", "diagnostics", "lipid vesicle", "hepatitis", "peptide", "amino acid", "gene", "envelope", "hepatitis B virus", "amino acid sequence", "envelope protein", "diluent", "carrier", "cross-linking", "out surface", "novel peptide", "surface antigen", "synthetic peptide analog", "viral protein", "allergen", "protein", "human", "animal", "invention", "antigen", "antibody" ], "name": "Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.20861.3d", "type": "Organization" }, { "id": "https://www.grid.ac/institutes/grid.250415.7", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-5158769-A" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:26", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_02983.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-5158769-A'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-5158769-A'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-5158769-A'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-5158769-A'


 

This table displays all metadata directly associated to this object as RDF triples.

99 TRIPLES      15 PREDICATES      55 URIs      35 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-5158769-A schema:about anzsrc-for:3114
2 schema:author N6de7bc55e57343969d2f370a9bc494d4
3 schema:citation sg:pub.10.1007/bf02327089
4 sg:pub.10.1038/289373a0
5 sg:pub.10.1038/295158a0
6 sg:pub.10.1038/317145a0
7 sg:pub.10.1038/318663a0
8 https://doi.org/10.1002/j.1460-2075.1982.tb01262.x
9 https://doi.org/10.1056/nejm198502213120806
10 https://doi.org/10.1073/pnas.78.6.3824
11 https://doi.org/10.1073/pnas.79.24.7871
12 https://doi.org/10.1073/pnas.80.16.4949
13 https://doi.org/10.1126/science.6200931
14 https://doi.org/10.1159/000149327
15 https://doi.org/10.3109/08820138309066866
16 schema:datePublished 1992-10-27T00:00
17 schema:description <p>A hepatitis B vaccine containing a peptide with an amino acid chain of at least six consecutive amino acids within the pre-S gene coded region of the envelope of hepatitis B virus. The vaccine being free of an amino acid sequence corresponding to the naturally occurring envelope proteins of hepatitis B virus and a physiologically acceptable diluent. The peptide being free or linked to a carrier. The carrier being a conventional carrier or a novel carrier including a lipid vesicle stabilized by cross-linking and having covalently bonded active sites on the outer surface thereon. Such novel carrier being useful not only to link the novel peptide containing an amino acid chain with amino acids within the pre-S gene coded region of the surface antigen of hepatitis B virus, but can also be used to bind synthetic peptide analogues of other viral proteins, as well as bacterial, allergen and parasitic proteins of man and animals. The peptides of the invention can be utilized in diagnostics for the detection of antigens and antibodies.</p>
18 schema:keywords allergen
19 amino acid
20 amino acid sequence
21 animal
22 antibody
23 antigen
24 carrier
25 cross-linking
26 diagnostics
27 diluent
28 envelope
29 envelope protein
30 gene
31 hepatitis
32 hepatitis B virus
33 human
34 immunogen
35 invention
36 lipid vesicle
37 novel peptide
38 out surface
39 peptide
40 protein
41 surface antigen
42 synthetic peptide analog
43 vaccine
44 viral protein
45 schema:name Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
46 schema:recipient https://www.grid.ac/institutes/grid.20861.3d
47 https://www.grid.ac/institutes/grid.250415.7
48 schema:sameAs https://app.dimensions.ai/details/patent/US-5158769-A
49 schema:sdDatePublished 2019-04-18T10:26
50 schema:sdLicense https://scigraph.springernature.com/explorer/license/
51 schema:sdPublisher N0e8cb46a540e4df28c07b21ccb2d0c61
52 sgo:license sg:explorer/license/
53 sgo:sdDataset patents
54 rdf:type sgo:Patent
55 N0e8cb46a540e4df28c07b21ccb2d0c61 schema:name Springer Nature - SN SciGraph project
56 rdf:type schema:Organization
57 N1c70c607044e4b01be966778664078c2 schema:name Stephen B. H. Kent
58 rdf:type schema:Person
59 N6de7bc55e57343969d2f370a9bc494d4 rdf:first N7a1f9acad1c34c3398af672e6b9fc5e7
60 rdf:rest Ne99f5b4b260445e98acc6d0ba2d27b4d
61 N7a1f9acad1c34c3398af672e6b9fc5e7 schema:name Alexander R. Neurath
62 rdf:type schema:Person
63 Ne99f5b4b260445e98acc6d0ba2d27b4d rdf:first N1c70c607044e4b01be966778664078c2
64 rdf:rest rdf:nil
65 anzsrc-for:3114 schema:inDefinedTermSet anzsrc-for:
66 rdf:type schema:DefinedTerm
67 sg:pub.10.1007/bf02327089 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023829055
68 https://doi.org/10.1007/bf02327089
69 rdf:type schema:CreativeWork
70 sg:pub.10.1038/289373a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032880486
71 https://doi.org/10.1038/289373a0
72 rdf:type schema:CreativeWork
73 sg:pub.10.1038/295158a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042872425
74 https://doi.org/10.1038/295158a0
75 rdf:type schema:CreativeWork
76 sg:pub.10.1038/317145a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048446499
77 https://doi.org/10.1038/317145a0
78 rdf:type schema:CreativeWork
79 sg:pub.10.1038/318663a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052023912
80 https://doi.org/10.1038/318663a0
81 rdf:type schema:CreativeWork
82 https://doi.org/10.1002/j.1460-2075.1982.tb01262.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1081617042
83 rdf:type schema:CreativeWork
84 https://doi.org/10.1056/nejm198502213120806 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034031480
85 rdf:type schema:CreativeWork
86 https://doi.org/10.1073/pnas.78.6.3824 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047301083
87 rdf:type schema:CreativeWork
88 https://doi.org/10.1073/pnas.79.24.7871 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034374371
89 rdf:type schema:CreativeWork
90 https://doi.org/10.1073/pnas.80.16.4949 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039287430
91 rdf:type schema:CreativeWork
92 https://doi.org/10.1126/science.6200931 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062635706
93 rdf:type schema:CreativeWork
94 https://doi.org/10.1159/000149327 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040985468
95 rdf:type schema:CreativeWork
96 https://doi.org/10.3109/08820138309066866 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035831916
97 rdf:type schema:CreativeWork
98 https://www.grid.ac/institutes/grid.20861.3d schema:Organization
99 https://www.grid.ac/institutes/grid.250415.7 schema:Organization
 




Preview window. Press ESC to close (or click here)


...